Wegovy is now approved for use to treat weight issues in Singapore; health authority removes unauthorised online sale listings

Adults who are obese, or who are overweight with at least one weight-related comorbidity, are eligible to take Wegovy. - Reuters

SINGAPORE, April 2 (The Straits Times/ANN): Wegovy, a higher-dose version of diabetes medication Ozempic whose weight loss side effects drew social media attention, has been approved by the Health Sciences Authority (HSA).

Adults who are obese, or who are overweight with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes or high cholesterol, are eligible to take Wegovy.